Robocath Companies

Rouen, France, November 30, 2021 – Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today announces the successful completion of the first coronary angioplasty in China assisted by its R-One™ robotic platform.

Last Funding Date: 2020
Industry: Health Care Equipment
Last Funding Type: Series C
Headquarters: Rouen, Haute-Normandie, France
Total Funding: 56219416
Funding Status: Late Stage Venture
Employee Number: 11-50
Technology: Biotechnology, Health Care, Medical, Robotics
Estimated Revenue: $1M to $10M
Founded Date: 2009-01-01